Nicholas A. Di Prospero

Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy

Amy M. Avila, Barrington G. Burnett, Addis A. Taye et al. · Journal of Clinical Investigation · 2007 · 341 citations · Full text

Hdac Inhibitors, Genetics, Smn2 Gene Expression +18

Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial

Nicholas A. Di Prospero, Angela Baker, Neal Jeffries et al. · The Lancet Neurology · 2007 · 297 citations

Neurodegenerative Diseases, Alzheimer's Disease, Neurological Disorder +10

Clinical features of spinal and bulbar muscular atrophy

Lindsay Fernández‐Rhodes, Brandi K. Freeman, Sungyoung Auh et al. · Brain · 2009 · 203 citations · Full text

Muscle Function, Clinical Features, Spinal Disorder +16

Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition

Debapriya Basu, Lesley-Ann Huggins, Diego Scerbo et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2018 · 161 citations · Full text

Low-density Lipoprotein, Hyperlipidemia, Obesity +17

Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial

Lindsay Fernández‐Rhodes, Angela Kokkinis, Michelle J. White et al. · The Lancet Neurology · 2011 · 155 citations · Full text

Clinical Trials, Bulbar Muscular Atrophy, Medicine +4